Unusual 11 Mid-Day Movers 10/28: (GRVY) (VRTS) (ITGR) Higher; (OPXA) (SNMX) (STON) Lower

October 28, 2016 12:57 PM EDT

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

Gravity (Nasdaq: GRVY) 125.6% HIGHER; reported Q3 EPS of KRW888, versus (KRW708) reported last year. Revenue for the quarter came in at KRW15.75 billion, versus KRW8.67 billion reported last year.

Opexa Therapeutics (Nasdaq: OPXA) 66.2% LOWER; announced that the Phase 2b Abili-T clinical trial designed to evaluate the efficacy and safety of Tcelna (imilecleucel-T) in patients with secondary progressive multiple sclerosis (SPMS) did not meet its primary endpoint of reduction in brain volume change (atrophy), nor did it meet the secondary endpoint of reduction of the rate of sustained disease progression. Tcelna did show a favorable safety and tolerability profile.

Senomyx (Nasdaq: SNMX) 47.6% LOWER; reported Q3 EPS of ($0.05), $0.02 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $6.02 million versus the consensus estimate of $5.36 million.

StoneMor Partners L.P. (NYSE: STON) 43.8% LOWER; announced a quarterly cash distribution of $0.33 per common unit for the 3rd quarter 2016. This represents a reduction of 50% from the prior year 3rd quarter.

eHealth (Nasdaq: EHTH) 39.8% LOWER; reported Q3 EPS of ($0.20), $0.15 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $32.1 million versus the consensus estimate of $36.02 million.

Virtus Investment Partners (Nasdaq: VRTS) 24.5% HIGHER; reported Q3 EPS of $1.64, $0.16 better than the analyst estimate of $1.48. Revenue for the quarter came in at $82.3 million versus the consensus estimate of $80.77 million.

McKesson (NYSE: MCK) 24.1% LOWER; reported Q2 EPS of $2.94, $0.11 worse than the analyst estimate of $3.05. Revenue for the quarter came in at $50 billion versus the consensus estimate of $51.21 billion. McKesson sees FY2017 EPS of $12.35-$12.85, versus the consensus of $13.59.

Integer Holdings Corp (NYSE: ITGR) 23.6% HIGHER; reported Q3 EPS of $0.83, $0.04 better than the analyst estimate of $0.79. Revenue for the quarter came in at $346.6 million versus the consensus estimate of $347.92 million.

AtriCure (Nasdaq: ATRC) 20.1% HIGHER; reported Q3 EPS of ($0.21), $0.07 better than the analyst estimate of ($0.28). Revenue for the quarter came in at $38.2 million versus the consensus estimate of $37.85 million.

Cytokinetics, Inc. (Nasdaq: CYTK) 19.4% HIGHER; reported total revenues for the third quarter of 2016 were $59.0 million, compared to $7.9 million, during the same period in 2015. The net income for the third quarter was $31.9 million, or $0.80 and $0.74 per basic and diluted share, respectively. This is compared to the net loss for the same period in 2015 of $(8.8) million, or $(0.23) per basic and diluted share.

Data I/o Corp (Nasdaq: DAIO) 18.2% HIGHER; reported Q3 EPS of $0.08, versus $0.00 reported last year. Revenue for the quarter came in at $6.6 million, versus $0 reported last year.

To get this report daily visit http://www.streetinsider.com/entities/Unusual+11+Mid-Day+Movers.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Special Reports

Related Entities

Unusual 11 Mid-Day Movers

Add Your Comment